v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
Common Stock
Additional Paid-in-Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Series A Convertible Preferred Stock
Preferred Stock
Beginning Balance, Shares at Dec. 31, 2024   558,511        
Beginning Balance at Dec. 31, 2024 $ (2,069,216) $ 6 $ 1,207 $ (609) $ (2,069,820)  
Issuance of common stock on vesting of restricted stock units, Shares   176,372        
Issuance of common stock on vesting of restricted stock units   $ 2 (2)      
Share-based compensation 28,488   28,488      
Foreign currency translation adjustments 14,744     14,744    
Net loss (2,321,159)       (2,321,159)  
Ending Balance, Shares at Jun. 30, 2025   734,883        
Ending Balance at Jun. 30, 2025 (4,347,143) $ 8 29,693 14,135 (4,390,979)  
Beginning Balance, Shares at Mar. 31, 2025   646,697        
Beginning Balance at Mar. 31, 2025 (2,752,694) $ 7 11,439 (343) (2,763,797)  
Issuance of common stock on vesting of restricted stock units, Shares   88,186        
Issuance of common stock on vesting of restricted stock units   $ 1 (1)      
Share-based compensation 18,255   18,255      
Foreign currency translation adjustments 14,478     14,478    
Net loss (1,627,182)       (1,627,182)  
Ending Balance, Shares at Jun. 30, 2025   734,883        
Ending Balance at Jun. 30, 2025 $ (4,347,143) $ 8 29,693 14,135 (4,390,979)  
Beginning Balance, Shares at Dec. 31, 2025 3,661,083         3,661,083
Beginning Balance at Dec. 31, 2025 $ 19,013,673         $ 19,013,673
Beginning Balance, Shares at Dec. 31, 2025   911,255        
Beginning Balance at Dec. 31, 2025 (9,940,459) $ 10 663,514 (4,900) (10,599,083)  
Sale of Series A-1 convertible preferred stock, Shares   0       558,116
Sale of Series A-1 convertible preferred stock 0 $ 0 0     $ 3,472,095
Issuance of common stock and pre-funded warrants for conversion of Series A convertible preferred stock,Shares   6,137,634       (4,219,199)
Issuance of common stock and pre-funded warrants for conversion of Series A convertible preferred stock 22,485,768 $ 61 22,485,707     $ (22,485,768)
Issuance of common stock under initial public offering, net of underwriters discounts, Shares   3,450,000        
Issuance of common stock under initial public offering, net of underwriters discounts 16,015,000 $ 35 16,014,965      
Issuance of shares under ELOC, Shares   313,996        
Issuance of shares under ELOC 13,778,100 $ 3 13,778,097      
Reclassification of deferred financing costs to additional paid-in capital upon consummation of public offering and sale of Series A convertible preferred stock $ (1,004,333)   (1,004,333)      
Issuance of common stock upon exercise of stock options, Shares 211,647 211,647        
Issuance of common stock upon exercise of stock options   $ 2 (2)      
Issuance of common stock on vesting of restricted stock units, Shares   260,237        
Issuance of common stock on vesting of restricted stock units   $ 2 (2)      
Share-based compensation $ 1,459,980   1,459,980      
Foreign currency translation adjustments 200,402     200,402    
Net loss $ (11,783,873)       (11,783,873)  
Ending Balance, Shares at Jun. 30, 2026 0          
Ending Balance at Jun. 30, 2026           $ 0
Ending Balance, Shares at Jun. 30, 2026   11,284,769        
Ending Balance at Jun. 30, 2026 $ 31,210,585 $ 113 53,397,926 195,502 (22,382,956)  
Beginning Balance, Shares at Mar. 31, 2026           0
Beginning Balance, Shares at Mar. 31, 2026   10,798,722        
Beginning Balance at Mar. 31, 2026 23,520,591 $ 110 38,606,840 (28,441) (15,057,918)  
Issuance of shares under ELOC, Shares   313,996        
Issuance of shares under ELOC 13,778,100 $ 3 13,778,097      
Reclassification of deferred financing costs to additional paid-in capital upon consummation of public offering and sale of Series A convertible preferred stock (165,111)   (165,111)      
Issuance of common stock on vesting of restricted stock units, Shares   172,051        
Issuance of common stock on vesting of restricted stock units     0      
Share-based compensation 1,178,100   1,178,100      
Foreign currency translation adjustments 223,943     223,943    
Net loss $ (7,325,038)       (7,325,038)  
Ending Balance, Shares at Jun. 30, 2026 0          
Ending Balance at Jun. 30, 2026           $ 0
Ending Balance, Shares at Jun. 30, 2026   11,284,769        
Ending Balance at Jun. 30, 2026 $ 31,210,585 $ 113 $ 53,397,926 $ 195,502 $ (22,382,956)